Rent.Com.Au Limited

RNT

Rent.com.au Ltd. operates real estate websites focusing on the rental property market. The primary Websites operated by the Company are www.rent.com.au and www.rentpay.com.au. The firm offers products and tools, including Renter Resume, RentBond, RentConnect, RentCheck, RentPay and Rent tools, created to simplify the renting process for renters, landlords and agents. RentCheck verifies tenant’s identity (ID) and uses government records and a rental check on the Equifax National Tenancy Database (NTD) including the Australian Government's Document Verification Service (DVS), to give property managers and landlords comfort that tenant’s rental application is trustworthy. RentBond is a rental bond loan. The company is a way for tenants to pay their rental bond, two weeks' rent in advance, and any other moving costs, via a personal loan that is repaid over time. RentPay is a secure, portable payments and planning application, just for renters.

Metcash Limited

MTS

Metcash Ltd. engages in wholesaling, distributing, supplying, and supporting independent retailers and several other businesses networks. The company is headquartered in North Sydney, New South Wales and currently employs 9,000 full-time employees. The company went IPO on 2005-04-08. The firm provides merchandising, operational and marketing support for its food, liquor and hardware customers. Its segments include food, liquor and hardware. The food segment distributes a range of products and services to independent supermarkets and convenience retail outlets. The hardware segment is engaged in the distribution of hardware products to independent retail outlets and the operation of corporate and joint venture retail stores. The liquor segment distributes liquor products to independent retail outlets and hotels. The company provides various liquor brands, including Thirsty Camel, Big Bargain Bottleshop and Duncans. The firm's hardware brands include Mitre 10, Home Hardware, Total Tools and Hardings Hardware. The firm provides services to independent retailers in various corners of Australia, including Cape York and Cooktown in the Northeast, and Dampier and Broome in the Northwest.

Vanguard Diversified High Growth Funds

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Kogan.Com Ltd

KGN

Kogan.com Ltd. engages in the business of a portfolio of retail and services. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2016-07-07. The Company’s businesses include Kogan Retail, Kogan Marketplace, Kogan Mobile, Kogan Internet, Kogan Insurance, Kogan Money, Kogan Energy, Kogan Travel, Dick Smith, Matt Blatt, Mighty Ape and Brosa. Its segments include Kogan.com and Mighty Ape. Kogan.com segment is an online retailer selling in-house and third-party brand household and consumer electronics products, as well as providing services for telecommunication, Internet, insurance, home finances, utilities, vehicles and travel. The Mighty Ape segment is an online specialist retailer of gaming and entertainment products. Its offering comprises products released under Kogan.com’s brands, such as Kogan, Ovela, Fortis, Certa and Komodo, and products sourced from imported and domestic third party brands such as Apple, Canon, Swann, and Samsung. The company trades through various channels, including the Kogan.com Website and Apps and the Dick Smith Website.

Mesoblast Limited

MSB

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. The company is headquartered in Melbourne, Victoria and currently employs 73 full-time employees. The company went IPO on 2004-12-16. The company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. The company is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. The company has established commercial partnerships in Europe and China for certain Phase III assets.